CONCORDE ASSET MANAGEMENT, LLC Relmada Therapeutics, Inc. Transaction History

CONCORDE ASSET MANAGEMENT, LLC portfolio value:

$433,000
portfolio value

Relmada Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 11.7K shares 433K $37.02 11.7K